Automated bone scan index as predictors of survival in prostate cancer

Prostate cancer (PCa) is the second most diagnosed cancer in men. Early diagnosis and right management of PCa is critical to reducing deaths; the life expectancy is the main factors to be considered in the management of PCa. Among patients who die from PCa, the incidence of skeletal involvement appe...

Full description

Saved in:
Bibliographic Details
Main Authors: Joko Wiyanto, Rini Shintawati, Budi Darmawan, Basuki Hidayat, Achmad Kartamihardja
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2017-10-01
Series:World Journal of Nuclear Medicine
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.4103/1450-1147.215498
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850243905418690560
author Joko Wiyanto
Rini Shintawati
Budi Darmawan
Basuki Hidayat
Achmad Kartamihardja
author_facet Joko Wiyanto
Rini Shintawati
Budi Darmawan
Basuki Hidayat
Achmad Kartamihardja
author_sort Joko Wiyanto
collection DOAJ
description Prostate cancer (PCa) is the second most diagnosed cancer in men. Early diagnosis and right management of PCa is critical to reducing deaths; the life expectancy is the main factors to be considered in the management of PCa. Among patients who die from PCa, the incidence of skeletal involvement appears to be >85%. Bone scan (BS) is the most common method for monitoring bone metastases in patients with PCa. The extent of bone metastasis was also associated with patient survival until now there is no clinically useful technique for measuring bone tumors and includes this information in the risk assessment. An alternative approach is to calculate a BS index (BSI) and it has shown clinical significance as a prognostic imaging biomarker. Some computer-assisted diagnosis (CAD) systems have been developed to measure BSI and are now available. The aim of this study was to investigate automated BSI (aBSI) measurements as predictors' survival in PCa. Retrospectively cohort studied fifty patients with PCa who had undergone BS between January 2010 and December 2011 at our institution. All data collected was updated up to August 2016. CAD system analyzing BS images to automatically compute BSI measurements. Patients were stratified into three BSI categories BSI value 0, BSI value ≤1 and BSI value >1. Kaplan–Meier estimates of the survival function and the log-rank test were used to indicate a significant difference between groups stratified in accordance with the BSI values. A total of 35 subjects deaths were registered, with a median survival time 36 months after the follow-up BS of 5 years. Subjects with low aBSI value had longer overall survival in comparison with the other subjects (P = 0.004). aBSI measurements were shown to be a strong prognostic survival indicator in PCa; survival is poor in high-BSI value.
format Article
id doaj-art-adca679f15ee4ef38199e0fae9ea4e9a
institution OA Journals
issn 1450-1147
1607-3312
language English
publishDate 2017-10-01
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format Article
series World Journal of Nuclear Medicine
spelling doaj-art-adca679f15ee4ef38199e0fae9ea4e9a2025-08-20T01:59:53ZengThieme Medical and Scientific Publishers Pvt. Ltd.World Journal of Nuclear Medicine1450-11471607-33122017-10-01160426627010.4103/1450-1147.215498Automated bone scan index as predictors of survival in prostate cancerJoko Wiyanto0Rini Shintawati1Budi Darmawan2Basuki Hidayat3Achmad Kartamihardja4Department of Nuclear Medicine and Molecular Imaging, Dr. Hasan Sadikin General Hospital, Faculty of Medicine Universitas Padjadjaran, Jawa BaratDepartment of Nuclear Medicine and Molecular Imaging, Dr. Hasan Sadikin General Hospital, Faculty of Medicine Universitas Padjadjaran, Jawa BaratDepartment of Nuclear Medicine and Molecular Imaging, Dr. Hasan Sadikin General Hospital, Faculty of Medicine Universitas Padjadjaran, Jawa BaratDepartment of Nuclear Medicine and Molecular Imaging, Dr. Hasan Sadikin General Hospital, Faculty of Medicine Universitas Padjadjaran, Jawa BaratDepartment of Nuclear Medicine and Molecular Imaging, Dr. Hasan Sadikin General Hospital, Faculty of Medicine Universitas Padjadjaran, Jawa BaratProstate cancer (PCa) is the second most diagnosed cancer in men. Early diagnosis and right management of PCa is critical to reducing deaths; the life expectancy is the main factors to be considered in the management of PCa. Among patients who die from PCa, the incidence of skeletal involvement appears to be >85%. Bone scan (BS) is the most common method for monitoring bone metastases in patients with PCa. The extent of bone metastasis was also associated with patient survival until now there is no clinically useful technique for measuring bone tumors and includes this information in the risk assessment. An alternative approach is to calculate a BS index (BSI) and it has shown clinical significance as a prognostic imaging biomarker. Some computer-assisted diagnosis (CAD) systems have been developed to measure BSI and are now available. The aim of this study was to investigate automated BSI (aBSI) measurements as predictors' survival in PCa. Retrospectively cohort studied fifty patients with PCa who had undergone BS between January 2010 and December 2011 at our institution. All data collected was updated up to August 2016. CAD system analyzing BS images to automatically compute BSI measurements. Patients were stratified into three BSI categories BSI value 0, BSI value ≤1 and BSI value >1. Kaplan–Meier estimates of the survival function and the log-rank test were used to indicate a significant difference between groups stratified in accordance with the BSI values. A total of 35 subjects deaths were registered, with a median survival time 36 months after the follow-up BS of 5 years. Subjects with low aBSI value had longer overall survival in comparison with the other subjects (P = 0.004). aBSI measurements were shown to be a strong prognostic survival indicator in PCa; survival is poor in high-BSI value.http://www.thieme-connect.de/DOI/DOI?10.4103/1450-1147.215498artificial neural networksbone metastasesbone scanbone scan indexcomputer-assisted diagnosisprostate cancersurvival analysis
spellingShingle Joko Wiyanto
Rini Shintawati
Budi Darmawan
Basuki Hidayat
Achmad Kartamihardja
Automated bone scan index as predictors of survival in prostate cancer
World Journal of Nuclear Medicine
artificial neural networks
bone metastases
bone scan
bone scan index
computer-assisted diagnosis
prostate cancer
survival analysis
title Automated bone scan index as predictors of survival in prostate cancer
title_full Automated bone scan index as predictors of survival in prostate cancer
title_fullStr Automated bone scan index as predictors of survival in prostate cancer
title_full_unstemmed Automated bone scan index as predictors of survival in prostate cancer
title_short Automated bone scan index as predictors of survival in prostate cancer
title_sort automated bone scan index as predictors of survival in prostate cancer
topic artificial neural networks
bone metastases
bone scan
bone scan index
computer-assisted diagnosis
prostate cancer
survival analysis
url http://www.thieme-connect.de/DOI/DOI?10.4103/1450-1147.215498
work_keys_str_mv AT jokowiyanto automatedbonescanindexaspredictorsofsurvivalinprostatecancer
AT rinishintawati automatedbonescanindexaspredictorsofsurvivalinprostatecancer
AT budidarmawan automatedbonescanindexaspredictorsofsurvivalinprostatecancer
AT basukihidayat automatedbonescanindexaspredictorsofsurvivalinprostatecancer
AT achmadkartamihardja automatedbonescanindexaspredictorsofsurvivalinprostatecancer